Phase I-II

Castor bolsters trial solutions platforms to reach more patients and gain RWE

15-Nov-2022 By Maggie Lynch

Castor adds to its existing decentralized and hybrid clinical trial solutions platform to collect RWE, expand trials to global populations, and integrate virtual trial visits.

Clario releases 20 years of data working on decentralized trials

10-Nov-2022 By Ben Hargreaves

The company reveals some of its data on the number of trials and patients that have been supported through its tools.

Oracle and ObvioHealth come together for ‘tight integration’ of data in APAC DCTs

10-Nov-2022 By Maggie Lynch

Oracle and ObvioHealth collaborate on clinical trial solutions using ObviGo to establish a “more complete clinical research ecosystem” in Asia Pacific region.

IQVIA cuts sales guidance as site staff shortages delay execution of deliveries

09-Nov-2022 By Nick Taylor

IQVIA has reduced its full-year sales guidance in response to factors including bottlenecks created by staff shortages at certain sites.

Medable targets oncology trials for decentralized offering

09-Nov-2022 By Ben Hargreaves

Medable announces the launch of a ‘patient-first’ oncology service that the company states will improve patient access, enrolment, and retention for clinical trials.

Anji Pharma and Population Health partner to progress lead candidates

31-Oct-2022 By Ben Hargreaves

The biopharma company and investment firm will cooperate to progress late-stage clinical assets in diabetes and chronic idiopathic constipation.

Industry body points to ‘clear and serious threat’ to clinical research in UK

26-Oct-2022 By Ben Hargreaves

The ABPI releases a report that shows the number of clinical trials taking place in the UK fell by a large amount between the years 2017 and 2021.

Benefiting from Bristol Myers’ input, ConcertAI rolls out digital trial solution

24-Oct-2022 By Nick Taylor

ConcertAI has introduced a digital trial solution informed by its collaboration with Bristol Myers Squibb to simplify patient identification, consent, IRB approval, and contract negotiations.

Ayala Pharmaceuticals reports promising data from Desmoid Tumors trial

19-Oct-2022

Updated interim results from Part A the RINGSIDE pivotal Phase 2/3 study of the company’s AL102 new drug showed consistent early tumor shrinkage with measures deepening over time, plus good tolerability at all doses.

Big Pharma backs push to compare carbon footprint of site-based and decentralized trials

19-Oct-2022 By Nick Taylor

The Pistoia Alliance has begun an initiative to measure and compare the carbon footprint of site-based and decentralized clinical trials.

Walmart steps into clinical trials claiming ability to improve diversity

18-Oct-2022 By Ben Hargreaves

Walmart joins rival retailers by launching its service for clinical trial recruitment, stating that it will focus on older, rural, women and minority populations.

“Significant Step Forward” for Actinogen’s Alzheimer’s treatment

12-Oct-2022 By Maggie Lynch

Clinical data findings from Actinogen’s Phase 2a study measuring the effects of Xanamem in patients with biomarker-positive Alzheimer’s Disease validated company’s ongoing program.

Lightship and Acclinate partner to improve clinical trial diversity

11-Oct-2022 By Ben Hargreaves

The two companies will work together with the aim of increasing access and engagement in clinical trials for underrepresented populations.

TransCelerate CEO: Speeding drug development a ‘win-win’ for all concerned

28-Sep-2022

TransCelerate BioPharma continues to work towards “bringing new medicines to patients faster”. We caught up with the organization’s CEO to hear about its main achievements over the past decade and learn about what comes next.

Q&A: Precision for Medicine VP on the present & future of personalized medicine

27-Sep-2022

Outsourcing-Pharma caught up with Esther Mahillo, VP of Operational Strategy and Feasibility, Precision for Medicine to talk about advancements in patient enrollment in oncology and rare disease clinical trials.

Epic launches program to ‘unify’ clinical research with care delivery

22-Sep-2022 By Ben Hargreaves

Epic’s Life Sciences program is released with the aim to connect providers, pharmaceutical companies, and medical device manufacturers to recruit research participants, expand clinical trial access, and to speed up therapy development.

Thermo Fisher hails PPD’s wins of ‘very large’ customers following merger

20-Sep-2022 By Nick Taylor

Thermo Fisher Scientific’s clinical service unit PPD has won some “very large” customers since becoming part of the broader group in a mega-merger, according to CEO Marc Casper.

Australian CRO Avance buys C3 Research to support sponsors as programs advance

15-Sep-2022 By Nick Taylor

Australian CRO Avance Clinical has expanded in North America by acquiring C3 Research Associates, positioning it to continue supporting sponsors as they move into later-phase studies that need US sites.

Bayer taps Clariness to build patient insights into clinical trial review process

13-Sep-2022 By Nick Taylor

Bayer Pharma has enlisted Clariness to support its new study review process by providing pre-clinical trial patient insights and post-trial feedback.

Use of RWE, AI elevating drug development: Sidley

12-Sep-2022 By Jenni Spinner

A fleet of legal professionals offers advice and perspective on important considerations when harnessing artificial intelligence and real-world evidence.

Real-world evidence helps accelerate research: Wolters Kluwer Health

12-Sep-2022 By Jenni Spinner

Experts from the health information specialist explain how the use of RWD and RWE has helped speed up and improve the development of therapies and vaccines.

Vaderis exits stealth as ex-Almac Discovery candidate enters clinical development

07-Sep-2022 By Nick Taylor

The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company

Clarify, Datavant team up to securely connect first-party and real-world data

07-Sep-2022 By Nick Taylor

The companies will work together to help clients connect information sources, giving stakeholders a better overview of the clinical patient experience.

CVS Health agrees to acquire Signify Health

06-Sep-2022 By Jenni Spinner

With the purchase, the company is looking to advance its plans to connect with potential trial participants and spread awareness of study participation.

DTRA glossary aims to promote adoption of decentralized format

06-Sep-2022 By Jenni Spinner

The Decentralized Trials and Research Alliance is offering the research resource to increase awareness, understanding, and acceptance of the study format.

Patient-centric approach benefits more than the patient: Quanticate

06-Sep-2022 By Jenni Spinner

A representative from the biometric contract research organization explains how taking a ‘patient comes first’ attitude can lead to a range of improvements.

People on the Move: September 2022

01-Sep-2022 By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Syneos joins with physIQ, InCarda on atrial fibrillation study

30-Aug-2022 By Jenni Spinner

The physIQ monitoring platform will be used to evaluate an inhaled treatment, developed by InCarda, that is intended to treat atrial fibrillation patients.

Charles River opens research facilities in California and Washington

30-Aug-2022 By Jane Byrne

Organization extends turnkey research facility network to San Diego, San Francisco, Thousand Oaks, and Seattle.

Celanese lands Gates Foundation grant for refillable contraceptive research

29-Aug-2022 By Jenni Spinner

The company has landed funding from the Bill and Melinda Gates Foundation for research and development on a prototype of a refillable contraceptive solution.

NIH awards SBIR grant to AVM for lymphoma drug research

25-Aug-2022 By Jenni Spinner

The National Institutes of Health grant to AVM Biotechnology will be used to evaluate a drug to treat non-Hodgkin’s lymphoma combined with standard of care.

BMS forges multi-year research partnership with PathAI

25-Aug-2022 By Jenni Spinner

The pharmaceutical company and the artificial intelligence pathology specialist will focus on translational research in oncology, fibrosis, and immunology.

Include patient voice at every stage of clinical processes: Within3

23-Aug-2022 By Jenni Spinner

A leader suggests considering patient views and needs all along the clinical development path reaps a number of benefits, including time and cost savings.

Outsourcing strategists thinking farther ahead than ever: CPHI

23-Aug-2022 By Jenni Spinner

The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.

Tech Innovations: August 2022

22-Aug-2022 By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

American Kidney Fund launches resources to engage patients of color

22-Aug-2022 By Jenni Spinner

The group has introduced a downloadable guide, interactive quiz, and other tools to inform patients from underrepresented communities about trial participation.

Is it time to start rethinking mobile clinical trial apps?

22-Aug-2022 By Jenni Spinner

A leader from the trial financial management specialist suggests apps used in trials could be adjusted to better suit patients, sites and other stakeholders.

BMS expands precision oncology portfolio with Turning Point acquisition

18-Aug-2022 By Jenni Spinner

The pharmaceutical company has completed acquisition of Turning Point Therapeutics, a company specializing in precision medicine solutions for cancer patients.

Merck engages Saama Technologies to build ‘clinical data layer’

18-Aug-2022 By Jenni Spinner

The pharma firm will leverage the ClinTech leader's Life Science Analytics Cloud to bolster development capabilities and accelerate pipeline progress.

Parkinson’s monitoring tech advances in NICE approval process

16-Aug-2022 By Jenni Spinner

The National Institute for Health and Care Excellence is weighing the viability of PD Neurotechnology’s PDMonitor system for Parkinson’s disease patients.

Predictive analytics could unlock precision medicine progress: AiCure

15-Aug-2022 By Jenni Spinner

An expert from the clinical insight specialist shares how predictive analytics could reveal info about medication adherence, disease progression, and more.

Improving patient adherence can elevate trial results: Sweetch

11-Aug-2022 By Jenni Spinner

A leader from the behavioral science specialist shares ways to use precision engagement and other methods to increase patient adherence in clinical studies.

Alzheimer’s research data questioned by Department of Justice

09-Aug-2022 By Jenni Spinner

After scientists and reporters raised red flags about a study, Cassava Sciences is being accused of falsifying data in pursuit of an Alzheimer’s treatment.

MCI OneHealth, MDClone team up to use synthetic data to accelerate research

09-Aug-2022 By Nick Taylor

The two companies are collaborating to generate subject data sets designed to help users find insights that can speed up research and improve patient care.

Pfizer to acquire sickle cell disease specialist for $5.4b USD

08-Aug-2022 By Jenni Spinner

Biopharmaceutical company Global Blood Therapeutics specializes in conditions that often disproportionately impact underrepresented communities, such as SCD.

People on the Move: August 2022

04-Aug-2022 By Jenni Spinner

This month’s announcements of appointments, partnerships, expansions, and mergers include Curia, Thread, TFF Pharmaceuticals, and other notable companies.

Medical specialty societies can benefit from regulatory progress: IQVIA

04-Aug-2022 By Jenni Spinner

An expert from the trial tech firm explains how the 21st Century Cures Act and other recent regulatory advancements can elevate clinical data registries.

Boehringer, Seqster ink 3-year health data deal to accelerate research

04-Aug-2022 By Nick Taylor

The pharmaceutical company has forged a partnership with the life-sciences tech firm in an effort to elevate data collection and speed up clinical studies.

Bilingual staff boost Spanish speaker interest in trials: study

02-Aug-2022 By Nick Taylor

A survey by SubjectWell indicates that having Spanish-speaking research personnel increases interest in trial participation among Latino potential patients.

GCP update: advice on what to expect and how to prepare

01-Aug-2022 By Jenni Spinner

With updates to the Guideline for Good Clinical Practice Advancements on the horizon, an industry expert offers some perspective on what might be ahead.